Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

v3.20.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Mar. 31, 2020
Dec. 31, 2019
CURRENT ASSETS    
Cash and cash equivalents $ 127,987 $ 457,331
Inventory 22,942 22,942
Total Current Assets 150,929 480,273
PROPERTY AND EQUIPMENT, NET
RIGHT-OF-USE ASSET 74,847 82,450
INTANGIBLE ASSETS, NET 2,440,286 2,501,592
DEBT ISSUANCE COSTS 500,000 500,000
PRE-ACQUISITION COSTS 3,171,075 2,588,441
DEPOSITS 3,253,253 3,253,253
TOTAL ASSETS 9,590,390 9,406,009
CURRENT LIABILITIES    
Accounts payable and accrued expenses 2,229,494 1,778,434
Accrued compensation and related liabilities 2,068,961 2,055,167
Accrued interest 1,823,155 1,734,527
Lease liabilities 75,538 82,882
Notes payable including current portion of long-term debt, net 4,647,569 1,369,856
Convertible notes payable 1,697,000 1,697,000
Derivative Liability 24,767,000
Total Current Liabilities 12,541,717 33,484,866
LONG-TERM LIABILITIES    
Long-term debt, net 15,592,296
TOTAL LIABILITIES 28,134,013 33,484,866
STOCKHOLDERS' DEFICIT    
Preferred stock - $0.001 par value; 50,000,000 shares authorized Series B, convertible; 13,000 shares issued and outstanding (aggregate liquidation preference of $1,300,000) 13 13
Common stock, $0.001 par value; 500,000,000 shares authorized; 352,206,749 and 344,029,434 shares issued and outstanding, respectively 352,206 344,029
Additional paid-in capital 31,348,398 31,259,365
Accumulated deficit (50,244,240) (55,682,264)
Total Stockholders' Deficit (18,543,623) (24,078,857)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 9,590,390 $ 9,406,009